Xiaoqiang Wang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Molecular Biology top 5%
- RNA modifications and cancer 7
- Geriatrics and Gerontology top 5%
- Aging top 10%
- Immunology and Allergy top 10%
-
- Cancer, Stress, Anesthesia, and Immune Response 13
-
- Asthma and respiratory diseases 10
-
- Estrogen and related hormone effects 8
-
- Trigeminal Neuralgia and Treatments 8
-
- Facial Nerve Paralysis Treatment and Research 7
- Co-authors
- Traci M. Tanaka HallPhillip D. ZamoreXuejun C. ZhangXinli LinJordan TangJeffrey A. LoyShiting LiBangbao Tao
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoqiang Wang
134 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 435
- Molecular Biology 1.6k
- Geriatrics and Gerontology 69
- Aging 29
- Immunology and Allergy 75
Countries citing papers authored by Xiaoqiang Wang
This map shows the geographic impact of Xiaoqiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqiang Wang more than expected).
Fields of papers citing papers by Xiaoqiang Wang
This network shows the impact of papers produced by Xiaoqiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqiang Wang. The network helps show where Xiaoqiang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoqiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 44 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 58 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 2 | |
| 15 | 2019 | 7 | |
| 16 | 2019 | 3 | |
| 17 | 2011 | 84 | |
| 18 | 2011 | 60 | |
| 19 | 2010 | 15 | |
| 20 | 2000 | 51 |
About Xiaoqiang Wang
Xiaoqiang Wang is a scholar working on Otorhinolaryngology, Developmental Neuroscience and Cancer Research, having authored 151 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer, Stress, Anesthesia, and Immune Response (13 papers), Asthma and respiratory diseases (10 papers), Cancer-related molecular mechanisms research (10 papers), Estrogen and related hormone effects (8 papers), MicroRNA in disease regulation (8 papers), Trigeminal Neuralgia and Treatments (8 papers), Facial Nerve Paralysis Treatment and Research (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (435 citations), Molecular Biology (1.6k citations) and Geriatrics and Gerontology (69 citations). Xiaoqiang Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Traci M. Tanaka Hall, Phillip D. Zamore, Xuejun C. Zhang, Xinli Lin, Jordan Tang, Jeffrey A. Loy, Shiting Li, Bangbao Tao, Suling Hong and Ke Xia. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.